Vol. 74 (1994): Supplement 186

Articles

• Proceedings of the 4th European Symposium on Psoriasis. Trieste, Italy, 16-19 September 1993

  Carmelo Sharpa

  1-183

  Published: 1994-02-01

  • PDF

• A population genetic study of psoriasis

  G Swanbeck, A Inerot, T Martinsson, J. Wahlström

  7-8

  Published: 1994-02-01

  • PDF

• Characterization of lesional psoriatic skin T lymphocyte clones

  M Barna, FG Snijdewint, FL van der Heijden, JD Bos, ML. Kapsenberg

  9-11

  Published: 1994-02-01

  • PDF

• Cellular interactions and adhesion molecules in psoriatic skin

  OJ de Boer, CE Verhagen, A Visser, JD Bos, PK. Das

  15-18

  Published: 1994-02-01

  • PDF

• Soluble intercellular adhesion molecule-1 and procollagen III peptide are reliable markers of disease severity in psoriasis

  F Ameglio, C Bonifati, M Carducci, L Alemanno, G Sacerdoti, M. Fazio

  19-20

  Published: 1994-02-01

  • PDF

• Differential expression of ICAM-1, E-selectin and VCAM-1 by endothelial cells in psoriasis and contact dermatitis

  PK Das, OJ de Boer, A Visser, CE Verhagen, JD Bos, ST. Pals

  21-22

  Published: 1994-02-01

  • PDF

• Interleukin-1-beta, interleukin-6, and interferon-gamma in suction blister fluids of involved and uninolved skin and in sera of psoriatic patients

  C Bonifati, F Ameglio, M Carducci, G Sacerdoti, M Pietravalle, M. Fazio

  23-24

  Published: 1994-02-01

  • PDF

• Serum levels of interferons and TNF-alpha are not correlated to psoriasis activity and therapy

  M Tigalonova, JR Bjerke, H Gallati, M Degré, S Jablonska, S Majewski, R. Matre

  25-27

  Published: 1994-02-01

  • PDF

• Neutrophil responsiveness in psoriasis

  F Rantuccio, D Sinisi, M Mastrolonardo, A Polignano, C Tortorella, S. Antonaci

  28-29

  Published: 1994-02-01

  • PDF

• The hyperperfusion of the psoriatic plaque correlates histologically with dilatation of vessels

  T Auer, M Bacharach-Buhles, S el-Gammal, M Stücker, B Panz, C Popp, K Hoffmann, M Happe, Altmeyer

  30-32

  Published: 1994-02-01

  • PDF

• Sonographic and NMR imaging study of sausage digit

  G Coari, A Iagnocco, M Mastrantuono, A De Cata, S Persia, R Passariello, A. Zoppini

  33-34

  Published: 1994-02-01

  • PDF

• Psoriatic scales: an ultrastructural study

  M Barbareschi, G Colzani, S Motta, A Angius, S Sesana, M. Monti

  35-36

  Published: 1994-02-01

  • PDF

• Lipoprotein peroxidation in adult psoriatic patients

  AM Offidani, G Ferretti, M Taus, O Simonetti, N Dousset, P Valdiguie, G Curatola, G. Bossi

  38-40

  Published: 1994-02-01

  • PDF

• Calcipotriol: clinical trial versus betamethasone dipropionate + salicylic acid

  C. Scarpa

  47

  Published: 1994-02-01

  • PDF

• Structural alterations of basal keratinocytes and capillary loop in psoriasis during treatment with topical calcipotriol

  GM Palleschi, A Gentili, M Caproni, A Giacomelli, D Falcos, P. Fabbri

  49-51

  Published: 1994-02-01

  • PDF

• Effect of calcitriol on growth, differentiation, chemokine mRNA expression of cultured keratinocytes and on keratinocyte-T cell binding

  P de Haan, S Sampat, EM van der Raaij, I Bruynzeel, DM Boorsma, R Willemze, TJ. Stoof

  52-54

  Published: 1994-02-01

  • PDF

• Treatment of psoriasis vulgaris with topical calcipotriol: is the clinical improvement of lesional skin related to a down-regulation of some cell adhesion molecules?

  ML Cagnoni, I Ghersetich, T Lotti, M Pierleoni, G. Landi

  55-57

  Published: 1994-02-01

  • PDF

• Notes on history of psoriasis

  A. Zampieri

  58-59

  Published: 1994-02-01

  • PDF

• Psoriasis and the nervous system

  C Pincelli, F Fantini, C Magnoni, A. Giannetti

  60-61

  Published: 1994-02-01

  • PDF

• Psoriasis, stress and psychiatry: psychodynamic characteristics of stressors

  M Mazzetti, A Mozzetta, GC Soavi, E Andreoli, PG Foglio Bonda, P Puddu, F. Decaminada

  62-64

  Published: 1994-02-01

  • PDF

• Experience with psoriasis in a psychosomatic dermatology clinic

  MM Polenghi, E Molinari, C Gala, R Guzzi, C Garutti, AF. Finzi

  65-66

  Published: 1994-02-01

  • PDF

• Plasma neuropeptide levels in psoriasis

  N Mozzanica, A Cattaneo, G Vignati, A. Finzi

  67-68

  Published: 1994-02-01

  • PDF

• Psoriatic arthritis: a clinical, radiological and genetic study of 58 Italian patients

  S Trabace, S Cappellacci, P Ciccarone, S Liaskos, R Polito, L. Zorzin

  69-70

  Published: 1994-02-01

  • PDF

• Is HLA B27 a true marker of axial involvement in psoriatic arthropathy?

  G Mazzanti, L Coloni, G DeSabbata, G. Paladini

  71-72

  Published: 1994-02-01

  • PDF

• A rare enthesopathy in psoriatic oligoarthritis

  R Scarpa, PR Ames, G della Valle, E Lubrano, P. Oriente

  74-75

  Published: 1994-02-01

  • PDF

• Peptide T: a new treatment for psoriasis? A review of our experiences

  T Talme, B Lund-Rosell, KG Sundquist, M Hilliges, O Johansson, L Wetterberg, JA. Marcusson

  76-78

  Published: 1994-02-01

  • PDF

• Fumaric acid esters (FAEs) suppress CD 15- and ODP 4-positive cells in psoriasis

  M Bacharach-Buhles, FM Pawlak, U Matthes, RK Joshi, P. Altmeyer

  79-82

  Published: 1994-02-01

  • PDF

• Anthralin: how does it act and are there more favourable derivatives?

  G Mahrle, B Bonnekoh, A Wevers, L. Hegemann

  83-84

  Published: 1994-02-01

  • PDF

• Tacalcitol in psoriasis: a video-microscopy study

  R Strumia, E Altieri, I Romani, V Bettoli, A Negrini, S. Trimurti

  85-87

  Published: 1994-02-01

  • PDF

• Intermittent cyclosporin A treatment of severe plaque psoriasis. Long-term follow-up of 26 patients

  AM Peluso, F Bardazzi, A Tosti, C. Varotti

  90-91

  Published: 1994-02-01

  • PDF

• Short-term treatment with cyclosporin in severe psoriasis: four years of experience

  A Garcovich, M Gatti, A Pompili, G Olivetti, F. Catamo

  92-93

  Published: 1994-02-01

  • PDF

• Short-term "cyclosporin A" therapy for psoriatic arthritis

  V Riccieri, A Sili Scavalli, A Spadaro, M Bracci, E Taccari, A. Zoppini

  94-95

  Published: 1994-02-01

  • PDF

• Psoriasis and cyclosporin: immunohistochemical aspects of the basement membrane

  MR Mondello, L Califano, SP Cannavò, D Di Mauro, B Guarneri, L Magaudda, S Pergolizzi, G Santoro, Vaccaro

  96-98

  Published: 1994-02-01

  • PDF

• Immunophilins and immunosuppression by cyclosporins and macrolide structures

  MH. Schreier

  100

  Published: 1994-02-01

  • PDF

• Cyclical immunotherapy in patients with psoriasis

  P Amerio, M Gravante, M Andreassi, S. Masci

  101-102

  Published: 1994-02-01

  • PDF

• The modern approach: new combined treatments for psoriasis

  AF. Finzi

  105-106

  Published: 1994-02-01

  • PDF

• Frequency of psoriatic arthritis in general population and among the psoriatics in Department of Dermatology

  V Barisić-Drusko, I Dobrić, A Pasić, D Paljan, Z Jukić, A Basta-Juzbasić, B. Marinović

  107-108

  Published: 1994-02-01

  • PDF

• Prevalence and clinical features of juvenile psoriatic arthritis in 425 psoriatic patients

  C Biondi Oriente, R Scarpa, P. Oriente

  109-110

  Published: 1994-02-01

  • PDF

• Calcium metabolism and psoriatic arthropathy

  M Lomuto, M Cammisa, M Iannantuono, G Ditano, G Ciavarella-Petracca, M. Pileri

  111-112

  Published: 1994-02-01

  • PDF

• The nails in psoriatic arthritis

  G Lavaroni, F Kokelj, P Pauluzzi, G. Trevisan

  113

  Published: 1994-02-01

  • PDF

• Methotrexate in psoriatic polyarthritis

  PD Pigatto, E Gibelli, R Ranza, A. Rossetti

  114-115

  Published: 1994-02-01

  • PDF

• Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study

  G Mazzanti, L Coloni, G De Sabbata, G. Paladini

  116-117

  Published: 1994-02-01

  • PDF

• Scintigraphic assessment of disease activity in psoriatic arthritis with 99m-Tc-labelled non-specific polyclonal human immunoglobulin G

  M Liberatore, AP Iurilli, O Barduagni, M Marini, A Centi Colella, L. Zorzin

  118

  Published: 1994-02-01

  • PDF

• Psoriasis and Lyme arthritis

  G Bianchi, L Buffrini, MC Grignolo, G Rovetta, F Crovato, P. Monteforte

  119-120

  Published: 1994-02-01

  • PDF

• Pharmacokinetics of acitretin

  WE Lambert, E Meyer, AP De Leenheer, J De Bersaques, AH. Kint

  122-123

  Published: 1994-02-01

  • PDF

• Interlamellar lipid differences between normal and psoriatic stratum corneum

  S Motta, S Sesana, M Monti, A Giuliani, R. Caputo

  131-132

  Published: 1994-02-01

  • PDF

• The pseudo-elongation of capillaries in psoriatic plaques

  M Bacharach-Buhles, S el Gammal, B Panz, P. Altmeyer

  133-137

  Published: 1994-02-01

  • PDF

• Cutaneous microcirculation in psoriasis. A videocapillaroscopic morphofunctional study

  GC Fuga, W Marmo, F Acierno, F Bassetti, F Leonetti, LM Pampanelli, G. Palermi

  138

  Published: 1994-02-01

  • PDF

• Psoriasis and endothelins

  G Trevisan, G Stinco, C Giansante, N Fiotti, P Vidimari, F. Kokelj

  139-140

  Published: 1994-02-01

  • PDF

• Fc gamma-receptors in skin and serum from patients with psoriasis, before and after therapy

  JR Bjerke, M Tigalonova, TS Jensen, R. Matre

  141-142

  Published: 1994-02-01

  • PDF

• Evaluation of serine alpha 1-antitrypsin and polymorphonuclear leukocyte elastase contents and their immunogenetic correlation in psoriasis

  G Nini, L Bianchi, E Angelini, V Corleto, S Gatti, AM. Carrozzo

  143-145

  Published: 1994-02-01

  • PDF

• Prevalence of alexithymic characteristics in psoriatic patients

  I Allegranti, T Gon, G Magaton-Rizzi, E. Aguglia

  146-147

  Published: 1994-02-01

  • PDF

• Psoriasis of the palms and soles is frequently associated with oropharyngeal Candida albicans

  RB Skinner Jr, EW Rosenberg, PW. Noah

  149-150

  Published: 1994-02-01

  • PDF

• Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation

  C Frati, L Bevilacqua, V. Apostolico

  151-153

  Published: 1994-02-01

  • PDF

• Characteristics and possible significance of the answers to Rorschach from patients suffering from psoriasis

  E Andreoli, PG Foglio Bonda, M Mazzetti, A Mozzetta, P Nicolai, P Puddu, F. Decaminada

  154-157

  Published: 1994-02-01

  • PDF

• Photofibrosis: a further histopathological change induced by PUVA therapy via the mast cell in guttate psoriasis. Preliminary report

  G Borroni, G Vignati, C Zaccone, A Gorani, V Brazzelli, G. Rabbiosi

  159-161

  Published: 1994-02-01

  • PDF

• PUVA-treated psoriatic skin as a model for cutaneous wrinkling assessed by skin replicas

  V Brazzelli, G Borroni, E Berardesca, E Romano, GP Vignoli, G. Rabbiosi

  162-163

  Published: 1994-02-01

  • PDF

• Ocular side effects of PUVA-treated patients refusing eye sun protection

  PG Calzavara-Pinton, A Carlino, E Manfredi, F Semeraro, C Zane, G. De Panfilis

  164-165

  Published: 1994-02-01

  • PDF

• Tacalcitol ointment for psoriasis

  M Nishimura, Y Makino, H. Matugi

  166-168

  Published: 1994-02-01

  • PDF

• Topical calcipotriol (MC 903) for psoriasis: a clinical study

  N Mozzanica, A Cattaneo, E Schmitt, A Legori, AF. Finzi

  169-170

  Published: 1994-02-01

  • PDF

• Topical calcipotriol for psoriasis--an immunohistologic study

  N Mozzanica, A Cattaneo, E Schmitt, R Diotti, AF. Finzi

  171-172

  Published: 1994-02-01

  • PDF

• Psoriasis vulgaris in 50 MHz B-scan ultrasound--characteristic features of stratum corneum, epidermis and dermis

  S el Gammal, T Auer, C Popp, K Hoffmann, P Altmeyer, C Passmann, H. Ermert

  173-176

  Published: 1994-02-01

  • PDF